Mary Fisher
Director · Dermata Therapeutics, Inc.
Individual
- 2026
- Jan 7, 2026
- 1
Filings (90d)
0
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Mary Fisher files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Munera Maria E. Bedoya-Toro - $1K in DRMA purchases and sales in the last 12 months
- Kathleen D. Scott - $13 in DRMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Mary Fisher?
Mary Fisher is a corporate insider, tracked as Director of Dermata Therapeutics, Inc. (DRMA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mary Fisher last file a Form 4?
The only primary Form 4 on record is dated 7 January 2026.